Cancers mass screening. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured MCF-7 Cells HCT116 Cells HT29 Cells Cell Line Lymph Nodes Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases53

Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Disease Progression Carcinoma, Squamous Cell Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Endometrial Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Liver Neoplasms Adenocarcinoma Head and Neck Neoplasms Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell Bone Neoplasms Neoplasms, Radiation-Induced Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Skin Neoplasms Precancerous Conditions Genital Neoplasms, Female Gastrointestinal Neoplasms Thyroid Neoplasms Neoplasms, Multiple Primary Mammary Neoplasms, Experimental Pharyngeal Neoplasms Kidney Neoplasms Disease Models, Animal Obesity Melanoma Testicular Neoplasms Carcinoma, Lobular Breast Neoplasms, Male Neoplastic Syndromes, Hereditary Neoplasms, Experimental Occupational Diseases Adenoma

Chemicals and Drugs51

Cancer Vaccines Neoplasm Proteins Antineoplastic Agents RNA, Messenger Tumor Markers, Biological Receptors, Estrogen Receptor, erbB-2 Prostate-Specific Antigen DNA, Neoplasm RNA, Small Interfering Tumor Suppressor Protein p53 Tamoxifen Fluorouracil Cisplatin Antineoplastic Agents, Phytogenic Receptors, Progesterone Antigens, Neoplasm Antineoplastic Agents, Hormonal Anticarcinogenic Agents Paclitaxel Antibodies, Monoclonal Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Deoxycytidine DNA-Binding Proteins Antimetabolites, Antineoplastic Receptors, Androgen RNA, Neoplasm Taxoids Transcription Factors Androgens BRCA2 Protein Nuclear Proteins Estrogens Proto-Oncogene Proteins Carcinogens Antibodies, Monoclonal, Humanized Proto-Oncogene Proteins c-akt BRCA1 Protein Protein Kinase Inhibitors Estrogen Receptor alpha DNA Primers Androgen Antagonists Quinazolines Membrane Proteins Peptides Carcinoembryonic Antigen Enzyme Inhibitors Protein-Serine-Threonine Kinases Organoplatinum Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment75

Mass Spectrometry Early Detection of Cancer Body Mass Index Tandem Mass Spectrometry Spectrometry, Mass, Electrospray Ionization Survival Analysis Survival Rate Prognosis Follow-Up Studies Retrospective Studies Prospective Studies Antineoplastic Combined Chemotherapy Protocols Risk Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Registries Xenograft Model Antitumor Assays Risk Assessment Neoplasm Staging Blotting, Western Sensitivity and Specificity Odds Ratio Risk Factors Combined Modality Therapy Neoplasm Transplantation Disease-Free Survival Chemotherapy, Adjuvant Transplantation, Heterologous Mammography Questionnaires Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Polymerase Chain Reaction Multivariate Analysis Predictive Value of Tests Tumor Burden Drug Screening Assays, Antitumor SEER Program Models, Biological Logistic Models Clinical Trials as Topic Molecular Targeted Therapy Transfection Confidence Intervals Radiotherapy Reproducibility of Results Neoplasm Grading Incidence Treatment Outcome Tissue Array Analysis Biopsy Gene Knockdown Techniques Flow Cytometry Tomography, X-Ray Computed Immunoenzyme Techniques Drug Administration Schedule Mammary Neoplasms, Experimental Palliative Care Chromatography, Liquid Mastectomy Immunohistochemistry Regression Analysis Disease Models, Animal DNA Mutational Analysis Genetic Testing Immunotherapy Cohort Studies Obesity Radiotherapy, Adjuvant Chromatography, High Pressure Liquid Colonoscopy Prostatectomy Drug Delivery Systems Neoplasms, Experimental

Psychiatry and Psychology1

Phenomena and Processes49

Body Mass Index Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Risk Drug Resistance, Neoplasm Mutation Sensitivity and Specificity Odds Ratio DNA Methylation Cell Survival Genotype Down-Regulation Cell Movement Genes, BRCA1 Cell Division Polymorphism, Genetic Dose-Response Relationship, Drug Cell Proliferation Cell Cycle Apoptosis Base Sequence Promoter Regions, Genetic Cell Growth Processes Transfection RNA Interference Diet Up-Regulation Amino Acid Sequence Gene Silencing Postmenopause Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Gene Expression Phenotype Phosphorylation Genes, p53 Signal Transduction Genes, BRCA2 Time Factors Alleles Obesity Premenopause Drug Synergism Epithelial-Mesenchymal Transition Menopause Epigenesis, Genetic Tumor Microenvironment Protein Binding

Disciplines and Occupations3

Medical Oncology Proteomics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Molecular Sequence Data Questionnaires SEER Program Base Sequence Amino Acid Sequence Incidence

Named Groups4

Survivors European Continental Ancestry Group African Americans Asian Continental Ancestry Group

Health Care35

Body Mass Index Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Prospective Studies Risk National Cancer Institute (U.S.)Registries Risk Assessment Age Factors Sensitivity and Specificity Odds Ratio Risk Factors Disease-Free Survival Questionnaires Kaplan-Meier Estimate Multivariate Analysis Predictive Value of Tests SEER Program Logistic Models Clinical Trials as Topic American Cancer Society Confidence Intervals Reproducibility of Results Incidence Treatment Outcome Sex Factors Palliative Care Regression Analysis Age Distribution Genetic Testing Cohort Studies Occupational Exposure Confounding Factors (Epidemiology)

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Mass Spectrometry Early Detection of Cancer Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Body Mass Index Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Neoplasms Mice, Nude Gene Expression Regulation, Neoplastic Cancer Vaccines Neoplasm Proteins Tandem Mass Spectrometry Spectrometry, Mass, Electrospray Ionization Uterine Cervical Neoplasms Survival Analysis Genetic Predisposition to Disease Survival Rate Prognosis Follow-Up Studies Antineoplastic Agents Retrospective Studies Prospective Studies Carcinoma Disease Progression Antineoplastic Combined Chemotherapy Protocols Risk Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Drug Resistance, Neoplasm Carcinoma, Squamous Cell Urinary Bladder Neoplasms Reverse Transcriptase Polymerase Chain Reaction Carcinoma, Non-Small-Cell Lung Cell Line, Tumor National Cancer Institute (U.S.)Colorectal Neoplasms Gene Expression Profiling RNA, Messenger Mutation Tumor Markers, Biological Receptors, Estrogen Registries Xenograft Model Antitumor Assays Risk Assessment United States Neoplasm Staging Age Factors Survivors Receptor, erbB-2 Blotting, Western Sensitivity and Specificity Neoplasm Recurrence, Local Rectal Neoplasms Odds Ratio Risk Factors Combined Modality Therapy Neoplasm Transplantation Smoking Disease-Free Survival Prostate-Specific Antigen Endometrial Neoplasms Molecular Sequence Data DNA, Neoplasm Cell Transformation, Neoplastic RNA, Small Interfering DNA Methylation Chemotherapy, Adjuvant Cell Survival Tumor Suppressor Protein p53 Esophageal Neoplasms Genotype Tamoxifen Fluorouracil Transplantation, Heterologous Mammography Medical Oncology Neoplastic Stem Cells Questionnaires Breast Cisplatin Antineoplastic Agents, Phytogenic Down-Regulation Receptors, Progesterone Cell Movement Antigens, Neoplasm Antineoplastic Agents, Hormonal Oligonucleotide Array Sequence Analysis Liver Neoplasms Genes, BRCA1 Kaplan-Meier Estimate Cell Division Adenocarcinoma Polymerase Chain Reaction Multivariate Analysis Head and Neck Neoplasms

No FAQ available that match "cancers mass screening"